Abstract:Abstract Background Titanium-based compounds have been incorporated as promising antineoplastic metals. In our previous studies, dithiophenolato titanium (IV) Complex "DBT" and its chitosan nanocomposite "DBT-CSNPs" were prepared and we showed that these compounds have antibacterial activities, cytotoxic, and have abilities to bind with DNA helixes. Therefore, in this study, we evaluated the LD50 values of dithiophenolato titanium (IV)-complex ( DBT ) and its high thermal stable chitosan nanoparticles ( DBT-CSNPs ). Then their therapeutic effects against liver injuries induced by carbon tetrachloride ( CCl 4 ) were assessed and compared with cisplatin treatment. Additionally, the anti-proliferative activity of DBT and DBT-CSNPs against human liver cancer (HepG2) cell lines through the analysis of the cell cycle was evaluated. Methods Nine groups of rats were prepared: normal, DBT, DBT-CSNPs, CSNPs, CCl 4 , CCl 4 -DBT, CCl 4 -DBT-CSNPs, CCl 4 -CSNPs and CCl 4 -cisplatin. Liver histopathology and the biochemical markers involving oxidative stress, apoptosis, liver and kidney functions, and lipid profile were determined. Results The results revealed that the treatment with DBT-CSNPs and DBT after CCl 4 administration abolished liver damage since it reduced the apoptosis induced by CCl 4 via the reduction of DNA fragmentation, Bax and caspase- 8 with an elevation of Bcl2 and Bcl2/Bax ratio. Also, these treatments caused nonsignificant changes in the markers of oxidative stress. Therefore, liver histopathology and functions, lipid profile, and kidney functions were improved. Cisplatin treatment reduced liver injury with a degree less than DBT-CSNPs and DBT, but it induced nephrotoxicity. Administration of DBT-CSNPs and DBT to healthy rats for 14 days has no adverse effect. Also, the results showed that DBT-CSNPs and DBT inhibited the proliferation of HepG2 cells by arresting cells in the G2/M phase and inducing cell death. Conclusion DBT-CSNPs and DBT have a therapeutic effect against CCl4-induced liver injuries via the reduction of apoptosis induced by CCl4. Moreover, both compounds have antineoplastic activities against the HepG2 cell line. In all cases, DBT-CSNPs have a greater effect due to their nanostructure. Therefore, both compounds can be used in the pharmacological fields, particularly DBT-CSNPs.

Structure Modification Converts the Hepatotoxic Tacrine into Novel Hepatoprotective Analogs

QSAR Research of Novel Tetrandrine Derivatives Against Human Hepatocellular Carcinoma.

Tacrine First-Phase Biotransformation and Associated Hepatotoxicity: A Possible Way to Avoid Quinone Methide Formation

Re-evaluation of Tacrine Hepatotoxicity Using Gel Entrapped Hepatocytes.

The hepatoprotective effect of 4-phenyltetrahydroquinolines on carbon tetrachloride induced hepatotoxicity in rats through autophagy inhibition

A new class of potent liver injury protective compounds: Structural elucidation, total synthesis and bioactivity study

Hepatoprotective potential of a novel quinazoline derivative in thioacetamide-induced liver toxicity

Discovery of novel tacrine derivatives as potent antiproliferative agents with CDKs inhibitory property

Late-Stage Modification of Medicine: Pd-Catalyzed Direct Synthesis and Biological Evaluation of N -Aryltacrine Derivatives

Structure-based design and synthesis of anti-fibrotic compounds derived from para-positioned 3,4,5-trisubstituted benzene

Novel diarylated tacrine derivatives: Synthesis, characterization, anticancer, antiepileptic, antibacterial, and antifungal activities

Recent Developments in Tacrine-based Hybrids as a Therapeutic Option for Alzheimer's Disease

Differential chemoprotection against acetaminophen-induced hepatotoxicity by latentiated L-cysteines

Curative Role of Dithiophenolato Titanium (IV)-Chitosan Nanocomposite Complex Against Carbon Tetrachloride-Induced Liver Injuries

Structure Modification of Resveratrol and Pharmacological Activity

Design, synthesis, in vitro and in vivo evaluation of tacrine–cinnamic acid hybrids as multi-target acetyl- and butyrylcholinesterase inhibitors against Alzheimer's disease

Discovery of Hepatoprotective Activity Components from Thymus Quinquecostatus Celak. by Molecular Networking, Biological Evaluation and Molecular Dynamics Studies.

Lead optimization of novel quinolone chalcone compounds by a structure-activity relationship (SAR) study to increase efficacy and metabolic stability

Tacrine hybrids as multi-target-directed ligands in Alzheimer’s disease: influence of chemical structures on biological activities

Synthesis of novel oxazol-5-one derivatives containing chiral trifluoromethyl and isoxazole moieties as potent antitumor agents and the mechanism investigation

Structural Characterization and Hepatoprotective Activities of 2-(2-Phenylethyl)Chromone Derivatives from Highland Barley Monascus purpureus